Vanderbilt Ingram Cancer Center
-
Probing the pathogenesis of leukemia
A new mouse model reveals gene clusters important in a treatment-resistant form of leukemia. Read MoreFeb 27, 2014
-
Studies shed new light on breast cancer development
Rebecca Cook, Ph.D., assistant professor of Cancer Biology, has spent her life trying to understand what makes things grow, from seedlings in soil to tumor cells in the body. Read MoreFeb 20, 2014
-
Agreement sets stage for enhanced My Cancer Genome
Vanderbilt-Ingram Cancer Center (VICC) and GenomOncology have announced an agreement for the exclusive commercial development of a decision support tool based on My Cancer Genome, an online precision cancer medicine knowledge resource for physicians, patients, caregivers and researchers. Read MoreFeb 13, 2014
-
Photo: Blackhawk visits
The musical group Blackhawk recently performed for patients at Vanderbilt-Ingram Cancer Center. The group raises funds for the Cancer Center in honor of former bandmate Van Stephenson, who died from melanoma. Read MoreFeb 13, 2014
-
VICC debuts lung cancer screening program
Vanderbilt-Ingram Cancer Center has launched a new lung cancer screening program to provide low-dose CT scans for patients at high risk for the deadly disease. Current or former smokers ages 55 to 74 who have a history of 30 or more pack years of smoking are eligible for the scans. Read MoreJan 30, 2014
-
Vanderbilt-Ingram Cancer Center receives $100,000 ovarian cancer research grant from Kay Yow Cancer Fund
L-r: Lawrence Marnett, Mary Geddes Stahlman Professor of Cancer Research; Vanderbilt women’s head basketball coach Melanie Balcomb; Susan Donohoe, executive director of the Kay Yow Cancer Fund; Mayor Karl Dean; Vanderbilt-Ingram Cancer Center Director Jennifer Pietenpol; and Assistant Professor of Obstetrics and Gynecology Dineo Khabele were on hand for… Read MoreJan 21, 2014
-
Targeting tumor “supply lines”
A metabolic enzyme plays a crucial role in vascular development and may be a good target for cancer therapies. Read MoreDec 18, 2013
-
Research climate must be enhanced: NCI director
The director of the National Cancer Institute, Harold Varmus, M.D., told an overflow crowd at this year’s Orrin Ingram Distinguished Lecture that he is concerned about the climate for discovery research in the United States. Read MoreDec 5, 2013
-
Therapeutic target for synovial sarcoma
Inhibitors of a signaling pathway that is critical to synovial sarcoma tumorigenesis may be useful treatments for this aggressive cancer. Read MoreNov 21, 2013
-
Photo: Cancer survivorship celebration
More than 650 cancer survivors, family members and cancer health care providers attended Vanderbilt-Ingram Cancer Center’s Cancer Survivorship Celebration earlier this month during a special evening dinner and concert at the Loveless Barn in Nashville. Read MoreNov 21, 2013
-
National Cancer Institute director set for Discovery Lecture
The director of the National Cancer Institute, Harold Varmus, M.D., will deliver the next Flexner Discovery Lecture on Thursday, Nov. 21. His lecture, “New Directions in Cancer Research,” will begin at 4 p.m. in 208 Light Hall. Read MoreNov 14, 2013
-
Family’s support enhances cancer research training
John F. Brock III, chairman and CEO of Coca-Cola Enterprises, his wife, Mary, and their three children have established an endowment to support an oncology fellowship at Vanderbilt-Ingram Cancer Center. The Brock Family Fellowship will provide financial assistance long into the future for young physicians, postdoctoral students and medical investigators who are furthering their training in cancer research. Read MoreNov 14, 2013
-
Breast SPORE lands NCI renewal
Vanderbilt-Ingram Cancer Center’s Breast Specialized Program of Research Excellence (SPORE) has been awarded a third round of funding from the National Cancer Institute (NCI). Read MoreNov 7, 2013
-
VICC debuts new Center for Cancer Targeted Therapies
Vanderbilt-Ingram Cancer Center leaders formally dedicated the space for the new Center for Cancer Targeted Therapies (CCTT), located in the Infusion Center on the second floor of The Vanderbilt Clinic, at a special ribbon-cutting held during last week’s fall meeting of the Cancer Center’s Board of Overseers. Read MoreOct 31, 2013
-
Concert highlights upcoming cancer survivorship celebration
There are nearly 13 million cancer survivors in the United States thanks to intensive cancer research, improved treatments and cancer support programs. In celebration of cancer survivors and those patients who have passed away from the disease, Vanderbilt-Ingram Cancer Center, in partnership with Gilda’s Club Nashville, will host the 2013 Cancer Survivorship Celebration. Read MoreOct 10, 2013
-
Probing mutant EGF receptor regulation
Understanding the regulation of mutant EGF receptors commonly found in lung cancers could lead to new targeted therapies. Read MoreOct 10, 2013
-
Sosman named one of ‘hottest’ researchers in U.S.
Jeffrey Sosman, M.D., professor of Medicine, Ingram Chair for Cancer Research and director of the Vanderbilt Melanoma Program, was named one of the Hottest Scientific Researchers of the last year by Thomas Reuters Science Watch. Read MoreSep 26, 2013
-
Support group cares for cancer caregivers
Physical fatigue, anxiety and emotional distress are just some of the symptoms that caregivers may experience while undertaking the hard work of helping a friend or loved one cope with cancer. Read MoreSep 26, 2013
-
VU study identifies DNA changes in drug-resistant cancer cells
Vanderbilt investigators have combined next-generation sequencing technologies and bioinformatics analyses to screen for genome-wide genetic mutations associated with drug resistance in a series of lung cancer cell lines. Read MoreSep 12, 2013
-
Tumor factor spurs blood vessel growth
A newly identified factor regulates blood vessel growth in colorectal tumors and could be a promising target for cancer therapies. Read MoreAug 26, 2013